Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
December 2022
in “
Cells
”
cannabinoid compounds CBD THC endocannabinoid system CB1 receptor androgenetic alopecia dermatitis dermatomyositis eczema psoriasis wound healing scar formation skin inflammation hair growth hair follicle epithelial progenitor cells alopecia cannabinoids cannabidiol tetrahydrocannabinol hair loss skin diseases hair follicles
Studysummary This review examines the role of cannabinoid compounds in treating various skin conditions and suggests their potential as systemic and topical therapies, but it reports no new experimental results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on mdpi.com →